Article Information
History
- January 26, 2022.
Article Versions
- Version 1 (November 1, 2021 - 18:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Meredith A Mortberg1,
- Hien T Zhao2,
- Andrew G Reidenbach1,
- Juliana E Gentile1,
- Eric Kuhn3,*,
- Jill O’Moore4,
- Patrick M Dooley5,
- Theresa R Connors5,
- Curt Mazur2,
- Shona W Allen6,7,
- Bianca A Trombetta6,7,
- Alison McManus6,7,
- Matthew R Moore8,
- Jiewu Liu8,**,
- Deborah E Cabin4,
- Holly B Kordasiewicz2,
- Joel Mathews2,
- Steven E Arnold6,7,
- Sonia M Vallabh1,6,7,9,† and
- Eric Vallabh Minikel1,6,7,9,†
- 1Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA
- 2Ionis Pharmaceuticals Inc, Carlsbad, CA, 92010, USA
- 3Proteomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA
- 4McLaughlin Research Institute, Great Falls, MT, 59405, USA
- 5Massachusetts Alzheimer’s Disease Research Center, Massachusetts General Hospital, Boston, MA, 02114, USA
- 6McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, 02114, USA
- 7Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA
- 8Bioagilytix, Boston, MA, 02135, USA
- 9Prion Alliance, Cambridge, MA, 02139, USA
- ↵†Correspondence to: svallabh{at}broadinstitute.org or eminikel{at}broadinstitute.org, Broad Institute, 415 Main St., Cambridge, MA 02142; 617-714-7000